NCT00777062View on ClinicalTrials.gov

VIVITROL as a Treatment for Cocaine and Alcohol Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

September 30, 2013

Conditions
Cocaine DependenceAlcohol Dependence
Interventions
DRUG

VIVITROL (Naltrexone extended-release injectable suspension)

VIVITROL (Naltrexone extended-release injectable suspension), 380 mg injection at the start of weeks 2 and 6.

DRUG

Placebo

Placebo injection at the start of weeks 2 and 6.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

Sponsors

Collaborators (1)

Alkermes, Inc.
All Listed Sponsors
collaborator

Alkermes, Inc.

INDUSTRY

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pennsylvania

OTHER

NCT00777062 - VIVITROL as a Treatment for Cocaine and Alcohol Dependence | Biotech Hunter | Biotech Hunter